Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid

NCT05263505 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05263505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05263505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
February 21, 2022
Completion date
September 11, 2023
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cicatrizing conjunctivitis, mucous membrane pemphigoid